NCT01764230View on ClinicalTrials.gov

Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

July 31, 2007

Study Completion Date

January 31, 2008

Conditions
Hodgkin LymphomaHodgkin Disease
Interventions
DRUG

triptorelin

Throughout the course of chemotherapy, patients were administered triptorelin (Diphereline SR 3 mg, Ibsen) in the form of i.m. injections, always once a month and simultaneously with the chemotherapy.

Trial Locations (1)

62500

Brno University Hospital and Masaryk University School of Medicine, Brno

All Listed Sponsors
collaborator

Ministry of Health, Czech Republic

OTHER_GOV

lead

Masaryk University

OTHER

NCT01764230 - Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients | Biotech Hunter | Biotech Hunter